Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (19)

2024

  1. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure

  2. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

2023

  1. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

2022

  1. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  2. Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response

    Revista Espanola de Cardiologia

  3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

  4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  5. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

  6. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study

    International Journal of Cardiology, Vol. 361, pp. 116-123

2021

  1. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)

    Basic Research in Cardiology, Vol. 116, Núm. 1

  2. Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 927-934

2020

  1. Trends in cardiogenic shock management and prognostic impact of type of treating center

    Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 546-553

2019

  1. Impact of geriatric assessment variables on 30-day mortality among older patients with acute heart failure

    Emergencias, Vol. 31, Núm. 3, pp. 149-155

2017

  1. Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure

    American Journal of Cardiology, Vol. 120, Núm. 7, pp. 1151-1157

2016

  1. Circadian variation in the effectiveness of reperfusion therapy in ST-segment elevation myocardial infarction treated with primary angioplasty and circadian associations with prognosis

    Emergencias, Vol. 28, Núm. 5, pp. 327-332

  2. Tiempo de estancia prolongado en los pacientes ingresados por insuficiencia cardiaca aguda

    Gaceta Sanitaria, Vol. 30, Núm. 3, pp. 191-200

2015

  1. Monte Carlo simulations versus experimental measurements in a small animal PET system. A comparison in the NEMA NU 4-2008 framework

    Physics in Medicine and Biology, Vol. 60, Núm. 1, pp. 151-162

2013

  1. Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study

    International Journal of Cardiology, Vol. 167, Núm. 2, pp. 442-450